Related references
Note: Only part of the references are listed.Serum microRNA profiling in patients with glioblastoma: a survival analysis
Zhao Hua et al.
MOLECULAR CANCER (2017)
Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors
Xuling Lin et al.
NEURO-ONCOLOGY (2017)
Antibody-independent capture of circulating tumor cells of non-epithelial origin with the ApoStream® system
Priya Balasubramanian et al.
PLOS ONE (2017)
Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis
Wen-Ting Yan et al.
SCIENTIFIC REPORTS (2017)
Current detection technologies for circulating tumor cells
Zheyu Shen et al.
CHEMICAL SOCIETY REVIEWS (2017)
Melanoma Brain Metastasis Pseudoprogression after Pembrolizumab Treatment
Justine V. Cohen et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodules
Adam Szpechcinski et al.
CANCER LETTERS (2016)
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid
Elena I. Pentsova et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases
Yingmei Li et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma
Xiao Yue et al.
JOURNAL OF NEUROSURGERY (2016)
Metastatic colonization by circulating tumour cells
Joan Massague et al.
NATURE (2016)
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Jeanne Tie et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks
Yupeng Hong et al.
TUMOR BIOLOGY (2016)
Next-generation sequencing: advances and applications in cancer diagnosis
Simona Serrati et al.
OncoTargets and Therapy (2016)
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
Jacob J. Chabon et al.
NATURE COMMUNICATIONS (2016)
Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies
Parisa Momtaz et al.
ONCOTARGET (2016)
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
Christine A. Parkinson et al.
PLOS MEDICINE (2016)
Potential Diagnostic and Prognostic Value of Plasma Circulating MicroRNA-182 in Human Glioma
Yilei Xiao et al.
MEDICAL SCIENCE MONITOR (2016)
Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma
Nicole R. Parker et al.
SCIENTIFIC REPORTS (2016)
Diagnostic significance of cerebrospinal fluid EGFR mutation analysis for leptomeningeal metastasis in non-small-cell lung cancer patients harboring an active EGFR mutation following gefitinib therapy failure
Shinichi Sasaki et al.
RESPIRATORY INVESTIGATION (2016)
Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer
Jin Sun Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Brain Tumor Mutations Detected in Cerebral Spinal Fluid
Wenying Pan et al.
CLINICAL CHEMISTRY (2015)
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
Eleonor Olsson et al.
EMBO MOLECULAR MEDICINE (2015)
miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients
Johnny C. Akers et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
MicroRNA as potential biomarkers in Glioblastoma
Zammam Areeb et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord
Yuxuan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Isaac Garcia-Murillas et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
Leticia De Mattos-Arruda et al.
NATURE COMMUNICATIONS (2015)
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
Priscilla K. Brastianos et al.
CANCER DISCOVERY (2015)
A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies
Alessandra Drusco et al.
ONCOTARGET (2015)
Prediction of clinical outcome in glioblastoma using a biologically relevant nine-microRNA signature
Josie Hayes et al.
MOLECULAR ONCOLOGY (2015)
Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma
Feng Zhi et al.
NEURO-ONCOLOGY (2015)
Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas Evidence that miR200a-3p is regulated by O6-methylguanine methyltransferase and promotes temozolomide responsiveness
Yolande Berthois et al.
CANCER BIOLOGY & THERAPY (2014)
Correlation between cell free DNA levels and medical evaluation of disease progression in systemic lupus erythematosus patients
Suzan Tug et al.
CELLULAR IMMUNOLOGY (2014)
Sensitive Detection of EGFR Mutations in Cerebrospinal Fluid from Lung Adenocarcinoma Patients with Brain Metastases
Haihong Yang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
Circulating Tumor Cells in Prostate Cancer Diagnosis and Monitoring: An Appraisal of Clinical Potential
Giuseppe Galletti et al.
MOLECULAR DIAGNOSIS & THERAPY (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
A MiRNA Signature for Defining Aggressive Phenotype and Prognosis in Gliomas
Raffaela Barbano et al.
PLOS ONE (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology
Daoud Sie et al.
CELLULAR ONCOLOGY (2014)
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
Francois-Clement Bidard et al.
CANCER AND METASTASIS REVIEWS (2013)
Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas
Cuihua Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Intercellular Communication by Exosome-Derived microRNAs in Cancer
Bethany N. Hannafon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Detection of EGFRvIII mutant DNA in the peripheral blood of brain tumor patients
Mohamad A. Salkeni et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
Shuwei Qiu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer
Anneli Dowler Nygaard et al.
LUNG CANCER (2013)
Liquid biopsy: monitoring cancer-genetics in the blood
Emily Crowley et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors
Lakshmi Nayak et al.
NEUROLOGY (2013)
BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles
Walter W. Chen et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Prognostic Value of Free DNA Quantification in Serum and Cerebrospinal Fluid in Glioma Patients
Wei Shi et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma
Alexander Baraniskin et al.
NEURO-ONCOLOGY (2012)
MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity
Nadiya M. Teplyuk et al.
NEURO-ONCOLOGY (2012)
Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system
Alexander Baraniskin et al.
BLOOD (2011)
Detection of Epithelial Growth Factor Receptor Mutations in Cerebrospinal Fluid from Patients with Lung Adenocarcinoma Suspected of Neoplastic Meningitis
Masato Shingyoji et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
Caicun Zhou et al.
LANCET ONCOLOGY (2011)
Surgical Mortality at 30 Days and Complications Leading to Recraniotomy in 2630 Consecutive Craniotomies for Intracranial Tumors
Benjamin Lassen et al.
NEUROSURGERY (2011)
A Ten-microRNA Expression Signature Predicts Survival in Glioblastoma
Sujaya Srinivasan et al.
PLOS ONE (2011)
Elevated Levels of Cell-Free Circulating DNA in Patients with Acute Dengue Virus Infection
Tran Thi Ngoc Ha et al.
PLOS ONE (2011)
Detection of MYCN DNA in the Cerebrospinal Fluid for Diagnosing Isolated Central Nervous System Relapse in Neuroblastoma
Tomiko Kimoto et al.
PEDIATRIC BLOOD & CANCER (2011)
Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases
Akshal S. Patel et al.
ONCOTARGET (2011)
MiRNA-196 Is Upregulated in Glioblastoma But Not in Anaplastic Astrocytoma and Has Prognostic Significance
Yanlei Guan et al.
CLINICAL CANCER RESEARCH (2010)
Circulating Tumor Cells in Colorectal Cancer: Past, Present, and Future Challenges
Benjamin P. Negin et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2010)
Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades
Iris Lavon et al.
NEURO-ONCOLOGY (2010)
Quantitative detection of multiple gene promoter hypermethylation in tumor tissue, serum, and cerebrospinal fluid predicts prognosis of malignant gliomas
Bo-Lin Liu et al.
NEURO-ONCOLOGY (2010)
Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer
Shannon L. Stott et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Circulating tumour cells: their utility in cancer management and predicting outcomes
Matthew G. Krebs et al.
Therapeutic Advances in Medical Oncology (2010)
A simple biological imaging system for detecting viable human circulating tumor cells
Toru Kojima et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer
Heidi Schwarzenbach et al.
BREAST CANCER RESEARCH (2009)
Circulating DNA - Its origin and fluctuation
Maniesh van der Vaart et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Dieto Brandsma et al.
LANCET ONCOLOGY (2008)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Detection of mutations in EGFR in circulating lung-cancer cells
Shyamala Maheswaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
Tanja Fehm et al.
BREAST CANCER RESEARCH (2007)
BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions
Frank Diehl et al.
NATURE METHODS (2006)
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
JA Chan et al.
CANCER RESEARCH (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations
D Dressman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)